Casefiles 10: pancreatitis, AAA, renal failure Flashcards

1
Q

presentation of severe acute pancreatitis

A

fever, abdominal pain, leukocytosis, HEMOCONCENTRATION, elevated serum amylase, and HYPOXEMIA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Acute pancreatitis can cause local complications including ?

can also lead to systemic complications such as ?

A

hemorrhage, necrosis, fluid collection, and infection

pulmonary, cardiac, and renal dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

degree of amylase elevation (far greater than 3× normal value) is helpful in establishing the diagnosis, but does not correlate with ?

A

pancreatitis severity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

concerning findings in acute pancreatitis

A

fever, tachycardia, tachypnea, WBC of 18,000/mm3, elevation in LDH, elevations in AST and ALT, and low PaO2 demonstrated on arterial blood gas
-hypoxemia and tachypnea are worrisome signs that he may be on his way to developing respiratory failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

acute pancreatitis management

A

initial bolus of LR at 20 mL/kg in the emergency department followed by a continuous infusion of 3 mL/kg/hour, with interval assessment of vital signs, laboratory values, and urine output in 6 to 8 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Patients whose BUN levels do not decrease during reassessments are given ?, whereas patients whose BUN levels decrease can have ?

A

a repeat fluid bolus

fluid infusion rate reduced to 1.5 mL/kg/hour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

for certain acute pancreatitis patients the likelihood of developing respiratory failure is extremely high during the initial 24 hours, management?

A

the patient’s respiratory status is expected to worsen and his airways are likely to become more edematous following fluid resuscitation, it is not unreasonable to semielectively intubate the patient to secure his airway before the onset of florid respiratory failure
degree of respiratory dysfunction can be measured using the PaO2/FiO2 ratios

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

also check what in pancreatitis

A

cardiac dysfunction: BP and the need for pressers
renal dysfunction can be measured by quantifying UOP and serum Cr values
neurologic dysfunction can be measured by GCS
nutritional dysfunction so nutritional support
NOT ppx abx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

moderately severe acute pancreatitis is associated with ?

A

transient organ failure (less than 48 hours)

-may have local complications or systemic complications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

severe acute pancreatitis is associated with ?

A

persistent organ dysfunction (longer than 48 hours), which carries an overall mortality rate of 4%
may have pancreatic necrosis (mortality rate of 10%). which may become infected (mortality rate of 40% to 70%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how are peripancreatic fluid collections are different from pancreatic pseudocysts

A

In peripancreatic fluid collections the fluid is walled off by surrounding tissue rather than a fibrous pseudocapsule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

As the severe pancreatitis improves, areas of pancreatic necrosis undergo liquefaction producing a combination of solid and liquid structures that is commonly referred to as ?

A

pancreatic phlegmon
With continued improvement of the pancreatitis, the solid components of the phlegmon may breakdown, and at the same time, the local inflammatory response produces a fibrous response around the fluid collections to form pseudocysts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

infected pancreatic pseudocysts usually occur several weeks following the onset of severe acute pancreatitis and most can be treated with ?

A

percutaneous drainage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

pancreatic abscess is due to ?
which happens generally ? weeks after the onset of severe acute pancreatitis
the abscess contains ?
the preferred initial approach for this problem is ?

A

secondary infection involving the pancreatic phelgmon
3 to 6 weeks
infected solid and liquid material
drainage is the preferred initial approach for this problem, but some patients need surgical drainage/debridement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Ranson criteria

on admission

A
WBC more than 16,000/mm3
glucose more than 200mg/dL
older than 55 yrs
AST more than 250 U/L
LDH greater than 350 U/L
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Ranson criteria

48 hrs after admission

A
HCT fall of 10%
Ca2+ less than 8 mg/dL
serum urea nitrogen increase of 5 mg/dL
fluid requirement of more than 6L
base excess of more than 4 mEq/L
pO2 less than 60 mmHg
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

treatment of acute pancreatitis is mainly supportive, including ?

A

Maintenance of hydration is important to prevent secondary organ injuries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

oral or NPO for pancreatitis?

A

Oral diet does not worsen the course of acute pancreatitis and is beneficial in preventing infectious complications related to the pancreatitis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Delaying surgical debridement ? after disease onset in patients with pancreatic necrosis is associated with improved outcomes in comparison to patients treated with early surgical interventions.

A

beyond 30 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

The current recommendations for open or endovascular interventions for AAA are based on 3 things

A
  1. SIZE: Diameter greater than 5.5 cm in men or diameter 5.0 cm in women (risk of rupture is higher in women)
  2. GROWTH RATE: Rapid growth of more than 0.5 cm/6 months;
  3. SYMPTOMS: Symptomatic AAA (pain or distal embolism)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

an aneurysm exists when a segment of an artery increases in size to more than ?
caused by conditions that cause weakening of the arterial walls, including ?

A

50% of the normal diameter (ie, greater than 150% size of native artery)
collagen defects, inflammatory conditions, immune responses, and atherosclerotic changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

inherited conditions associated with aneurysm

A

Marfan syndrome, Ehlers-Danlos syndrome, and familial thoracic aneurysm and dissection (TAAD) syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

non modifiable AAA risk factors

A
*Older age (age older than 50 for men and age 60 for women)
Male sex (4× increased risk vs. female)
*Family history
Race (more common in Whites)
Height
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

modifiable AAA risk factors

A

Smoking
Hypertension
Elevated cholesterol levels
Obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

USPSTF AAA screening recommendations

A

one-time ultrasound screening in men age 65-75 who have ever smoked
selective screening for men age 65-75 who have never smoked

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

recommended AAA surveillance based on aneurysm size

A
  1. 6-2.9 cm re-examine in 5 years
  2. 0-3.4 cm every 3 years
  3. 5-4.4 cm every year
  4. 5-5.4 cm every 6 months
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

the most common reasons for secondary interventions following EVAR (endovascular aneurysm repair)

A

endoleaks: persistence of blood flow outside of the endograft following EVAR

28
Q

causes of endoleak types

A

Type I endoleak: inadequate sealing at either the proximal or distal endograft attachment sites.
Type II endoleak: blood flow into the aneurysm sac from patent branch vessels such as IMA and lumbar arteries.
Type III endoleak: a defect in the fabric of the endograft or leakage between separate graft components deployed.
Type IV endoleak: Leaking between the interstices of the graft fabric.
Type V endoleak or endotension: Aneurysm sac that remains pressurized without visible endoleaks

29
Q

aneurysm formation process is associated with ?

A

infiltration of the arterial wall by lymphocytes and macrophages, destruction of the elastin and collagen in the media and adventitia of the artery, and loss of smooth-muscle cells resulting in thinning of the arterial wall

30
Q

pproximately 85% of the AAAs are located in the ?

A

infrarenal aorta

31
Q

aneurysmectomy open approach

A

performed either by a trans-abdominal approach or a retroperitoneal approach
associated with extensive dissections and significant perioperative fluid shifts

32
Q

EVAR approach

A

a percutaneous approach generally gained through a puncture in the femoral artery

  • Under image-guidance, covered stent grafts are placed into the aorta and anchored to the normal aorta above the aneurysm and to the iliac arteries below the aneurysm
  • done for more than 75% of all AAA repairs in the US
33
Q

open vs EVAR

A

30-day mortality for open AAA repair is 4% to 5%, with average hospital stay of 9 days
30-day mortality after EVAR is 1% with an average hospital stay of 3 days
Procedure-related CV, pulm, and ID complications rates are significantly lower following EVAR

34
Q

?% of patients require secondary interventions within 6 years after EVAR
monitoring recommendations?

A

20% to 30%

CT scans at 1 month and 12 months following the procedures, as most endoleaks following repairs tend to present early

35
Q

reintervention rate of approximately ?% is seen following open AAA repairs
monitoring recommendations ?

A

20%

CT monitoring is recommended at 5-year intervals

36
Q

Patients diagnosed with AAA should have thorough pulse examination to look for ?

A

aneurysmal disease in other anatomic locations

37
Q

A patient with suspected ruptured AAA associated with hemodynamic instability should undergo ? rather than ?

A

exploration and attempted repair

rather than delaying the repair for confirmatory CT scan

38
Q

definition of chronic renal failure (CRF)

A

kidney damage of greater than 3 months duration and/or GFR less than 60 mL/1.73 m2

39
Q

chronic renal disease stages

A

Stage 1: Kidney damage with normal or increased GFR (GFR greater than 90 mL/min/1.73 m2)
Stage 2: Kidney damage with mild decrease in GFR (GFR 60-90)
Stage 3: Moderate decrease in GFR (GFR 30-59)
Stage 4: Severe decrease in GFR (GFR 15-29 predialysis stage)
Stage 5: Kidney failure (GFR less than 15, usually indication for chronic dialysis)

40
Q

Induction immunosuppressive therapy for renal transplant patients often involves the administration of ?
Alternatively, induction therapy can be initiated with ?, which are monoclonal antibodies targeting ?

A

polyclonal IgG antibodies targeting T cell receptors such as CD2, CD3, CD4, and CD25

daclizumab or basiliximab, targeting IL-2 receptors on T cells

41
Q

Cyclosporin (CSA)
mechanism?
SEs?

A

a calcineurin inhibitor; mechanism involves the inhibition of IL-2 production
SEs: nephrotoxicity, HTN, gingival hyperplasia, and hyperkalemia

42
Q

Tacrolimus
mechanism?
SEs?

A

a calcineurin inhibitor that inhibits the production of IL-2, IL-3, IL-4, and γ-interferon
significantly more potent than CSA
SEs: nephrotoxicity, HTN, hyperkalemia, hypomagnesemia, CNS symptoms (headaches, tremors, and seizures), and insulin resistance

43
Q

Sirolimus (Rapamycin)

A

a T cell inhibitor that acts through a pathway that is separate from the calcineurin pathway less nephrotoxic than CSA and tacrolimus, but its application is associated with thrombocytopenia, hyperlipidemia, and poor wound healing

44
Q

What electrolyte/metabolic considerations in renal failure patients?

A

Dietary K+ restriction if GFR approaching 20 to avoid hyperkalemia
prevent secondary hyperPTH with dietary phos restriction, phosphate binder admin at meal time, admin of synthetic 1,25-dihydroxyvitamin D, and subtotal parathyroidectomy for patients with uncontrolled secondary or tertiary hyperPTH

45
Q

What is one of the leading causes of LVH and contributes to significant morbidity and mortality in renal failure patients?
how to prevent/manage?
what also contributes to LVH and is very common in this population?

A

anemia
administration of recombinant human erythropoietin (EPO)
HTN

46
Q

What produces an immunodeficiency state that is not reversible with hemodialysis?
pts are at increased risk for ?

A

Uremia

developing bacterial, viral, mycobacterial, and fungal infections

47
Q

neurologic complications that occur with CRF

some of these neurologic conditions improve with ?

A

uremic encephalopathy, and uremic peripheral neuropathy that is a mixed motor and sensory distal neuropathy, and uremic autonomic neuropathy is a condition that produces postural hypotension and hypotension during dialysis

dialysis

48
Q

mechanism of hemodialysis (HD)

A

the dialysis machine or dialyzer has two spaces separated by a semipermeable membrane, where blood passes through one side of the membrane and dialysate passes on the other side of the membrane. Through diffusion, excess water and solutes pass from the blood to the dialysate, resulting in the elimination of excess water and waste.

49
Q

HD access requirements

A

specialized large bore venous access through which blood can be drawn of at a high rate (350-400 mL/min) through one lumen and then returned through a separate lumen.
classified as temporary access (days) or intermediate-term access (weeks to months)
typically in IJ, as subclavian is smaller and femoral has increased infection risk

50
Q

the two preferred long-term hemodialysis accesses for patients with CRF who are candidates for HD

A

Arteriovenous fistula (AVF) creation and arterial-venous graft (AVG) placement

51
Q

Brescia-Cimino Fistula (most common)

A

a fistula created between the radial artery and the cephalic vein in the nondominant wrist

52
Q

Alternative fistula for patients with inadequate forearm arteries or veins

A

a brachial artery-cephalic vein fistula or a brachial artery-basilica vein fistula in the upper arm can be created

53
Q

In patients without sufficient quality or caliber superficial veins in the upper extremities, a ? can be placed between the brachial artery and a vein in the same upper extremity
major disadvantages of AVG vs AVF?

A

gortex (PTFE) graft

shorter life span and higher infection risk

54
Q

ambulatory peritoneal dialysis (PD)

A

the peritoneal surface and the peritoneal microvasculature are the site of exchange of fluids and solutes between the patient and the dialysate

55
Q

The three most common causes of CRF treated by renal transplantation

A
diabetes mellitus (27%)
glomerular diseases (21%)
hypertension (20%)
56
Q

patients are considered for renal transplant when their GFR falls below ?

A

20 mL/min

57
Q

Recently reported living-donor transplantation results have shown graft survival rates of ?

A

95%, 80%, and 56% at 1, 5, and 10 years, respectively

58
Q

Induction therapy is primarily used to prevent early acute rejections
one of the following three antibodies is used for induction therapy in combination with other agents

A

Antithymocyte globulin (ATG): a polyclonal antibody
Basiliximab: a monoclonal antibody and an IL-2 receptor antagonist
Alemtuzumab: a monoclonal antibody against the CD52 receptor

59
Q

Maintenance therapy describes the long-term immunosuppression regimen prescribed for the prevention of rejections
combo regimen?

A

A calcineurin inhibitor, corticosteroids, and an antiproliferative agent (CSA or tacrolimus, prednisone, azathioprine or mycophenolate mofetil)
sirolimus may replace the calcineurin inhibitors to minimize nephrotoxicity

60
Q

Acute graft rejections occur in ?% of the patients following renal transplantation
occur when most commonly?
present how clinically?
treated with ?

A

10% to 20%
the first few weeks to months following transplantation
fever, malaise, hypertension, oliguria, weight gain, acute unexplained rise in serum creatinine (greater than 20-25%), and tenderness over the transplanted kidney
high-dose corticosteroids or monoclonal antibodies

61
Q

?% of patients develop some form of infection during the first year following renal transplantation, and infections during this period of time contribute to ?% of the mortality during the early post-transplant period
what type of infections?

A

30-60%
50%
bacterial first month, then OIs such as CMV, PJP, aspergillosis, toxoplasmosis, cryptococcosis, nocardiosis, and blastomycosis
TMP-SMX ppx to PJP infection

62
Q

Suppression of the immune system following solid organ transplantations increases the risk of ? in post-transplant patients 3 to 14 times above the general population
what types?

A

malignancy
viral-associated neoplasms, including SqCC related to HPV, Kaposi sarcoma related to EBV, cervical cancer related to HPV, and hepatocellular carcinoma related to hepatitis B and C

63
Q

Overall, what is the most common post transplant malignancy?
the occurrence is related to ?

A

lymphoma or lymphoproliferative disorder

the intensity and duration of anti-T cell therapy

64
Q

the most common cause of late allograft failure

believed to be produced by ?

A

chronic allograft nephropathy
cumulative insults to the graft including infections, acute rejections, ischemia-reperfusion, immunosuppression related injuries, and re-occurrence of underlying nephropathies

65
Q

the two major causes of mortality in the chronic dialysis population

A

Infections and dialysis access complications

66
Q

A condition such as ?, if not correctable will disqualify the patient from renal transplantation

A

urinary outflow obstruction